.webp)
Innovative approach addresses a critical challenge in immunotherapy, offering new hope in the fight against cancer
In a groundbreaking study, Professor Mira Barda-Saad and her team at the Goodman Faculty of Life Sciences, Bar-Ilan University, have introduced a revolutionary technique to rejuvenate natural killer (NK) cells, a crucial component of the immune system. Published on the cover of The EMBO Journal, their research tackles a significant hurdle in cancer immunotherapy—NK cell exhaustion.
Natural killer cells are essential for identifying and destroying cancerous and viral cells. Recent advancements in cancer treatment, notably through immunotherapeutic strategies like the Chimeric Antigen Receptor (CAR) approach, have significantly altered the treatment landscape. This method involves extracting patient cells, genetically modifying them to enhance their cancer-fighting abilities, and reintroducing them into the body. However, it has been observed that both T cells and NK cells, including those engineered in the lab, can become fatigued from the continuous battle against tumors, leading to a loss of function.
Addressing this challenge, Professor Barda-Saad's research team has pinpointed the root causes of NK cell dysfunction and developed a novel solution involving nanoparticles. These nanoparticles target and silence negative regulators within the patient’s body, restoring the vitality of NK cells without the need for cell extraction and genetic modification.
This innovative approach not only revitalizes exhausted NK cells directly within the patient but also offers a promising new direction for improving the efficacy of cancer immunotherapy. By bypassing traditional methods and enhancing NK cell activity through targeted nanoparticles, this breakthrough could pave the way for more effective and sustained cancer treatments.
.webp)
